GLENVIEW CAPITAL MANAGEMENT, LLC

Position in NVS — Novartis AG

CIK 1138995 NEW YORK, NY

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$13,620,378

New position

Shares Held

86,909

first reported quarter

Ownership

0.005%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#142

of 1,603 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GLENVIEW CAPITAL MANAGEMENT, LLC holds $155,328,104 across 4 Drug Manufacturers - General names. NVS ranks #4 (8.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	57,771	$69,292,276
2	ABBV	AbbVie Inc.	148,913	$37,472,467
3	AZN	Astrazeneca PLC	184,279	$34,942,983
4	NVS	Novartis AG This page	86,909	$13,620,378

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,620,378	86,909	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.